In a retrospective cohort of patients with melanoma in situ (MIS) with non-lentigo maligna/non-acral lentiginous (non-LM/non-ALM) subtypes, no local recurrences, metastases, or melanoma-specific ...

A newly developed risk-prediction tool for invasive melanoma demonstrated enhanced accuracy, identifying 74% of future cases by screening the top 40% of the predicted risk population. Researchers ...

Mitotic rate ≥1/mm² and residual tumor presence are linked to higher relapse risk in cutaneous melanoma patients post-excision. Lymphovascular invasion significantly correlates with worse relapse-free ...

Stage 1 melanoma is treatable with surgery, and when combined with early detection, proper care and regular follow-ups, it offers a favorable outlook. Stage 1 melanoma is treatable with surgery, and ...

Prognostic features and clinical panthological factors of cutaneous malignant melanoma. The first group, WLE, represents the reference group used for Log-Rank Test Pairwise Comparisons. *represents p ...